CLOTTING FACTOR SÖZCÜĞÜ İNGILIZCE DİLİNDE NE ANLAMA GELİR?
pıhtılaşma
Pıhtılaşma, kanın bir sıvıdan jele dönüştüğü süreçtir. Potansiyel olarak hemostazı, hasar gören bir damardan kan kaybının kesilmesini ve onarımı ile sonuçlanır. Pıhtılaşma mekanizması, fibrin birikimi ve olgunlaşması ile birlikte trombositlerin aktivasyonu, yapışması ve toplanmasını içerir. Pıhtılaşma bozuklukları, kanama veya tıkanık pıhtılaşma ile sonuçlanabilen hastalık durumlarıdır. Koagülasyon, biyoloji boyunca oldukça korunmaktadır; Tüm memelilerde pıhtılaşma, hücresel ve protein bileşenlerini içerir. İnsanlardaki sistem en kapsamlı olarak araştırılmış ve en iyi anlaşılmıştır. Koagülasyon, kan damarında bir hasarın gemiyi astarlayan endotele zarar vermesinden hemen sonra başlar. Endotelin altındaki alana kan maruziyeti iki süreç başlatır: trombositteki değişiklikler ve subendotilyal doku faktörünün plazma Faktörü VII'ye maruz kalması, sonuç olarak fibrin oluşumuna yol açar. Trombositler hemen yaralanma yerine bir fiş oluşturur; buna birincil hemostaz denir.
İngilizce sözlükte clotting factor sözcüğünün tanımı
Sözlükteki pıhtılaşma faktörünün tanımı, kan VIII faktörü de dahil olmak üzere, kan pıhtılaşması için gerekli olan bir grup maddenin herhangi biridir: Pıhtılaşma faktörü.
«CLOTTING FACTOR» İLE İLİŞKİLİ İNGILIZCE KİTAPLAR
clotting factor sözcüğünün kullanımını aşağıdaki kaynakça seçkisinde keşfedin.
clotting factor ile ilişkili kitaplar ve İngilizce edebiyattaki kullanımı ile ilgili bağlam sağlaması için küçük metinler.
1
Human Physiology: From Cells to Systems
However, chemical linkages rapidly form between adjacent strands to strengthen
and stabilize the clot meshwork. This cross-linkage process is catalyzed by a
clotting factor known as factor XIII (fibrin-stabilizing factor), which normally is ...
Depending on the remaining amount of coagulation factor, mild, moderate and
severe forms of hemophilia are distinguished; two-thirds of cases are severe. In
hemophilia, as a result of the clotting factor deficiency, blood does not coagulate
...
Marshall Cavendish Corporation,
2007
3
Blood: Principles and Practice of Hematology
Patient Plasma 4- aPTT aPTT Result: Correction Interpretation: Clotting Factor
Deficiency EXPLANATION EXPLANATION Free Inhibitor Target • Deficient
Plasma (0% Factor -X') Normal Plasma ( 100% Factor "X") 1:1 Mix (50% Factor "X
") ...
Robert I. Handin, Samuel E. Lux, Thomas P. Stossel,
2003
4
Advanced Nutrition and Human Metabolism
Fibrin Sequence of reactions ➀ Inactive clotting factor X ➁ Vitamin K and Calcium
➃ Fibrinogen Prothrombin (factor II) Factor Xa ➂ Thrombin (factor IIa) Fibrin (
soluble) ➃ Fibrin stabilizing factor (XIIIa) Fibrin (insoluble) A series of reactions ...
Sareen Gropper, Jack Smith,
2008
5
Handbook of Pediatric Transfusion Medicine
Types of Clotting Factor for Treating Hemophilia Clotting factor concentrates
come from two sources, either human plasma donations or production via
recombinant methods from cell cultures. Currently produced human plasma-
derived factor ...
Christopher D. Hillyer, Christopher Hillyer, Ronald Strauss,
2004
6
Biological Monitoring: An Introduction
There is no Factor VI because it has been shown to be activated Clotting Factor V
(Clotting Factor Va: accelerator globulin or proaccelerin). Coagulation involves
interaction of plasma proteins to form a stable fibrin gel. ultimately leading to clot
...
7
Thrombosis and Hemorrhage
The severity of bleeding correlates with the plasma concentration of the clotting
factor (37). Those with a level of factor VIII less than 1% of normal (i.e., severe
hemophilia) have spontaneous hemorrhages and ecchymoses, usually develop
...
Joseph Loscalzo, Andrew I. Schafer,
2003
8
The Absite Question Review Book: Basic Sciences Edition
Exposed collagen, prekallikrein, HMW kininogen, and Clotting Factor 12. What is
the extrinsic pathway activated by? Tissue factor and Clotting Factor 7. Which
clotting factor is the convergence point of both extrinsic and intrinsic pathways?
William M. Greenberg,
2010
9
Medical-surgical Nursing: Patient-centered Collaborative Care
Coagulation or bleeding disorders can result from a clotting factor defect. Defects
include the inability to produce a specific clotting factor, production of low
quantities of a clotting factor, or production Of a less active form of a clotting factor
.
Donna D. Ignatavicius, M. Linda Workman,
2012
10
Consultative Hemostasis and Thrombosis: Expert Consult - ...
Factor VIII dose to be administered = % factor IX dose; 1 U factor VIII concentrate
per kilogram is estimated to raise the clotting factor VIII activity level in plasma by
2%. Consider the use of recombinant factor VIII or IX concentrates in those ...
«CLOTTING FACTOR» TERİMİNİ İÇEREN HABERLER
Ulusal ve uluslararası basında konuşulanları ve
clotting factor teriminin aşağıdaki haberlerde hangi bağlamda kullanıldığını keşfedin.
Omega 3: What is benefits and its source
Omega-3 (EPA) good for the heart: lowers blood pressure, prevents hardening of the arteries and reduces the clotting factor in the blood that ... «Standard Republic, Tem 15»
Hemophilia Therapeutics Market – Global Industry Analysis and …
Hemophilia is a rare, inherited disorder in which blood doesn't clot normally due to the lack of sufficient blood clotting factor. Clotting factor is a ... «Medgadget.com, Haz 15»
Biotech Stocks for you to follow - Biogen Inc (NASDAQ:BIIB …
ALPROLIX is a recombinant, clotting factor IX therapy and is currently approved for the treatment of hemophilia B in the U.S., Canada, Japan ... «Wall Street Observer, Haz 15»
EMA accepts marketing authorization application of Alprolix for …
Alprolix is a recombinant, clotting factor IX therapy and is currently approved for the treatment of haemophilia B in the US, Canada, Japan and ... «pharmabiz.com, Haz 15»
Sisters tells how their worst fears came true when they passed on …
Both sisters need clotting factor replacement if they have an operation because of their risk of bleeding. They didn't know anything about ... «Scottish Daily Record, Haz 15»
Large Cap Stocks Buzz - Baxter (BAX), Kinder Morgan (KMI …
Individuals with hemophilia B lack the ability to produce clotting factor IX and are today treated with infusions of plasma-derived or recombinant ... «Techsonian, Haz 15»
Biogen and Sobi Announce European Medicines Agency Validates …
ALPROLIX is a recombinant, clotting factor IX therapy and is currently ... therapy to demonstrate prolonged clotting factor circulation in the body. «MarketWatch, Haz 15»
Novo Nordisk reports positive results from phase 3 trial of Novoeight …
... people with hemophilia A must replace the missing factor VIII protein, which is accomplished by intravenous injection of the clotting factor. «pharmabiz.com, Haz 15»
Hot Action in 3 Biotech Stocks -Kite Pharma Inc (NASDAQ:KITE …
The company, on June 09, 2015, declared that the company will present new data on its long-acting clotting Factor VIIa-CTP (MOD-5014) at the ... «Wall Street Observer, Haz 15»
Novoeight provided long-term efficacy and safety in the treatment of …
... muscles, or organs because they are missing this clotting factor. To manage the disease and stop bleeding, people with haemophilia A must ... «European Pharmaceutical Review, Haz 15»